
Created by: Hellenbrecht (ELIC) , generated 2006/03/14, last changed: 2012/11/09
Exchange of information regarding GEP data management and analysis strategies with ELN partners.
Implementation and optimization of the biostatistical next generation sequencing platform and making it available for further collaborations, working groups and data sets in Europe that were so far not able to handle their respective data.
Data upload and analysis is now available within one system. New biostatistical methods were evaluated or developed including
Under the leadership of Haferlach and the ELN WP13 ROCHE invented based on the MILE study their own AmpliChip Leukemia in 2007.